Strategic Advisors’s Usana Health Sciences USNA Stock Holding History

Strategic Advisors’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,874	Closed	-$346K	–	158
2018 Q3	$346K	Buy	+2,874	New	+$357K	0.13%	120

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Strategic Advisors's USNA Position: Q4 2018 in Review

Strategic Advisors sold out of Usana Health Sciences (USNA) in Q4 2018, closing a stake of 2,874 shares — an estimated $346K sold.

Strategic Advisors first reported a position in USNA in Q3 2018 and held it in 1 quarter. The position peaked at $346K in Q3 2018. 190 funds tracked by Wall St. Rank hold USNA as of Q4 2018.

Strategic Advisors reported no remaining Usana Health Sciences position as of Q4 2018 after selling out during the quarter.
Strategic Advisors sold 2,874 Usana Health Sciences shares in Q4 2018, an estimated $346K.
Strategic Advisors first reported a position in Usana Health Sciences in Q3 2018 and held it in 1 quarter.
Strategic Advisors's Usana Health Sciences position peaked at $346K in Q3 2018.
190 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2018.

Based on Strategic Advisors's 13F filing for Q4 2018, filed 24 Jan 2019.